Late presentation in HIV-infected injecting drug users - a huge challenge for the Romanian health-care system

被引:4
作者
Ianache, Irina [1 ]
Calistru, Petre [1 ,2 ]
Tardei, Gratiela [1 ]
Ruta, Simona [2 ,3 ]
Oprea, Cristiana [1 ,2 ]
机构
[1] Victor Babes Clin Hosp Infect & Trop Dis, Bucharest, Romania
[2] Carol Davila Univ Med & Pharm, Bucharest, Romania
[3] Stefan S Nicolau Inst Virol, Bucharest, Romania
来源
ROMANIAN JOURNAL OF LEGAL MEDICINE | 2016年 / 24卷 / 02期
关键词
HIV; IDUs; late presentation; MYCOBACTERIUM-TUBERCULOSIS; COINFECTION; DIAGNOSIS; PREVALENCE; DISEASE;
D O I
10.4323/rjlm.2016.122
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
Background. HIV-infected injecting drug users (HIV-IDUs) are a major challenge to the Romanian healthcare system due to their high morbidity, mortality and health-care costs. Objective. The aim of this study was to determine the prevalence of late presenters (LP) among HIV-IDUs admitted to "Victor Babes" Clinical Hospital for Infectious Diseases, Bucharest and to evaluate their demographic and clinical characteristics. Methods. We performed a prospective study on HIV-IDUs diagnosed with severe immunosuppression, admitted between January 2009 and December 2014. HIV-IDUs with CD4 cell counts <350/mm(3) were considered LP and those with CD4 to a tertiary facility <200/mm(3) were defined with advanced HIV disease (AHD). These two groups were compared to a group of the HIV-IDUs that was diagnosed early in the evolution of illness (CD4 cell count >350/mm(3)). Statistical analysis was performed using SPSS v 20.0. Results. Out of 495 HIV-IDUs admitted during the study period, 238 (48.0%) were LP and 168 (33.7%) had AHD. The proportion of LP increased from 37.5% in 2009 to 52.6% in 2014 (0<0.001). Almost all HIV-IDUs, regardless of CD4 cell count, were young males (413, 83.4%), from urban areas (453, 91.5%), unemployed (393, 79.3%) and with low educational level (381, 76.9%). The median age at drug use initiation of 19 years (IQR 16-24) and the median duration of drug use at 9 years (IQR 4-13), were similar in both groups. More than half of all HIV-IDUs initially used intravenous heroin and afterwards legal highs (339, 68.4%) and (81, 16.3%) used only legal highs. The median CD4 cell count for the LPs was 104 cells/mm(3) (IQR 24-220) and the median HIV viral load 5.44 log10 copies/mL (IQR 5.00-6.00). Compared to early diagnosed HIV-IDUs (257), late presenters were more frequently diagnosed with opportunistic infections, especially tuberculosis (117, 49.1%) vs. (37, 14.3%), p<0.0001 and severe bacterial infections, mainly respiratory (54, 22.6%) vs. (46, 17.8%) p=0.02. Mortality was higher in LPs versus early presenters IDU (7, 2.7%) vs. (54, 22.6%) respectively p<0.0001. Conclusions. The proportion of LPs among HIV-IDUs diagnosed in our hospital increased alarmingly over the last few years. There were no significant differences regarding socio-demographic characteristics and drug use behaviour between late presenters and those diagnosed early, but LPs were more often diagnosed with opportunistic infections and had a significantly higher mortality rate.
引用
收藏
页码:122 / 127
页数:6
相关论文
共 34 条
[1]  
[Anonymous], SWISS MED WKLY
[2]  
[Anonymous], 2012, Joint EMCDDA and ECDC rapid risk assessment HIV in injecting drug users in the EU/EEA, following a reported increase of cases in Greece and Romania
[3]  
[Anonymous], 2012, HIV OUTBREAK INJECTI
[4]  
[Anonymous], HIV AIDS SURV EUR 20
[5]  
Apetrei C, 1998, AIDS, V12, P1079, DOI 10.1097/00002030-199809000-00015
[6]  
Botescu A., 2012, RISK ASSESSMENT NEW
[7]   Clinical care of the HIV-infected drug user [J].
Bruce, R. Douglas ;
Altice, Frederick L. .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2007, 21 (01) :149-+
[8]   Late presenters among persons with a new HIV diagnosis in Italy, 2010-2011 [J].
Camoni, Laura ;
Raimondo, Mariangela ;
Regine, Vincenza ;
Salfa, Maria Cristina ;
Suligoi, Barbara .
BMC PUBLIC HEALTH, 2013, 13
[9]  
Celesia BM, 2013, EUR REV MED PHARMACO, V17, P2218
[10]   Tuberculosis and Illicit Drug Use: Review and Update [J].
Deiss, Robert G. ;
Rodwell, Timothy C. ;
Garfein, Richard S. .
CLINICAL INFECTIOUS DISEASES, 2009, 48 (01) :72-82